NASDAQ · Biotechnology

HRTX (HRTX) Stock

$0.51 +3.06% NASDAQ: HRTX Healthcare

Valuation

MetricValue
Price$0.51
Market Cap$96.80M
P/E Ratio-7.08
P/B Ratio9.60
P/S Ratio0.89
EPS (TTM)$-0.12
52-Week High$2.30
52-Week Low$0.38
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-142.86%
ROA-7.81%
ROCE-21.43%
Gross Margin-1.29%
Operating Margin-1.94%
Net Margin-20.53%
Debt/Equity15.50
Current Ratio2.48

Annual Financials (USD)

Metric20212022202320242025
Revenue$86.0M$108.0M$127.0M$144.0M$155.0M
Operating Profit$-218.0M$-175.0M$-111.0M$-12.0M$-3.0M
Net Profit$-221.0M$-182.0M$-111.0M$-14.0M$-20.0M
EPS$-2.24$-1.67$-0.80$-0.09$-0.12
Op Margin-252.3%-162.2%-87.1%-8.0%-1.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$306.0M$251.0M$223.0M$233.0M$256.0M
Total Liabilities$228.0M$237.0M$256.0M$267.0M$242.0M
Cash$91.0M$15.0M$29.0M$26.0M$29.0M
Borrowings$159.0M$157.0M$180.0M$178.0M$141.0M

Latest News

New Strong Sell Stocks for July 15th Zacks · Jul 15, 2026 Heron Therapeutics (HRTX) Stock Sees Fair Value Cut After Cinvanti Patent Decision Simply Wall St. · Jul 12, 2026 Is Heron Therapeutics, Inc. (HRTX) Stock a Recovery Opportunity After Cinvanti Patent Court Ruling? Insider Monkey · Jun 30, 2026 Heron Therapeutics Receives Nasdaq Minimum Bid Price Notification MT Newswires · Jun 26, 2026 Why Did FULC, MVIS, HRTX Stocks Plunge To 52-Week Lows Today? Stocktwits · Jun 3, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-203.0M$-147.0M$-59.0M$-23.0M$-28.0M
Investing Cash Flow$30.0M$-5.0M$16.0M$17.0M$16.0M
Financing Cash Flow$0$0$0$0$-150.0M
Net Cash Flow$-15.0M$-75.0M$13.0M$-3.0M$3.0M
Free Cash Flow$-206.0M$-149.0M$-60.0M$-24.0M$-28.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-15.63%
Quick Ratio1.51
Interest Coverage—
Return 1Y-79.18%
Return 3Y-66.56%
Return 5Y-96.70%

Ownership

Insiders Held0.90%
Institutions Held82.23%
Institutions Float Held82.98%
Institutional HolderSharesReport Date
Rubric Capital Management LP30,046,8282026-03-31
Clearline Capital, LP12,235,2392026-03-31
Blackrock Inc.10,106,4222026-03-31
Orbimed Advisors LLC.9,816,9402026-03-31
Velan Capital Investment Management LP8,753,2902026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CHRS $1.27 +0.40% -2.21 $155.46M 0.00%
EPRX $6.05 +4.13% -5.99 $202.55M 0.00%
GNFTGenfit S.A. $8.95 +4.07% 261.07 $445.68M 0.00%
IVVD $0.55 +3.10% -3.53 $162.51M 0.00%
MDWD $14.35 -1.85% -7.94 $184.34M 0.00%

About HRTX

HRTX is led by CEO Craig Alexander Collard, employs 122 people, headquartered in US, publicly traded since 1987.

HRTX stock trades at $0.51 with a market capitalization of $96.80M. The stock is valued at a price-to-earnings (P/E) ratio of -7.08, price-to-book of 9.60, price-to-sales of 0.89. Over the past 52 weeks the stock has ranged between $0.38 and $2.30, and currently trades 77.8% below its 52-week high.

On profitability, HRTX generates a return on equity (ROE) of -142.86%, return on capital employed of -21.43%, an operating margin of -1.94%, a net profit margin of -20.53%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides